|
|
Volumn 344, Issue 6187, 2014, Pages 967-969
|
|
Target small firms for antibiotic innovation
a,c,d
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
IVACAFTOR;
ANTIINFECTIVE AGENT;
ANTIBIOTICS;
DRUG DEVELOPMENT;
INDUSTRIAL PRODUCTION;
POLICY MAKING;
RESEARCH AND DEVELOPMENT;
BASIC RESEARCH;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
FUNDING;
HUMAN;
PRIORITY JOURNAL;
PUBLIC-PRIVATE PARTNERSHIP;
SHORT SURVEY;
TAX;
UNITED KINGDOM;
UNITED STATES;
COMMERCIAL PHENOMENA;
COMMUNICABLE DISEASES;
DRUG DEVELOPMENT;
ECONOMICS;
FINANCIAL MANAGEMENT;
LEGISLATION AND JURISPRUDENCE;
MANAGEMENT;
MEDICAL RESEARCH;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRESCRIPTION;
STANDARDS;
STATISTICS AND NUMERICAL DATA;
SUPPLY AND DISTRIBUTION;
TRENDS;
ANTI-BACTERIAL AGENTS;
BIOMEDICAL RESEARCH;
CAPITAL FINANCING;
CLINICAL TRIALS, PHASE I AS TOPIC;
CLINICAL TRIALS, PHASE II AS TOPIC;
CLINICAL TRIALS, PHASE III AS TOPIC;
COMMUNICABLE DISEASES;
DRUG APPROVAL;
DRUG DISCOVERY;
DRUG PRESCRIPTIONS;
HUMANS;
POLICY MAKING;
SMALL BUSINESS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84901603869
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1251419 Document Type: Short Survey |
|
Times cited : (14)
|
|
References (9)
|
